עקוב אחר
Dhruva Katrekar
Dhruva Katrekar
Senior Scientist, Arc Institute
כתובת אימייל מאומתת בדומיין arcinstitute.org
כותרת
צוטט על ידי
צוטט על ידי
שנה
In vivo RNA editing of point mutations via RNA-guided adenosine deaminases
D Katrekar, G Chen, D Meluzzi, A Ganesh, A Worlikar, YR Shih, ...
Nature methods 16 (3), 239-242, 2019
1682019
In situ gene therapy via AAV-CRISPR-Cas9-mediated targeted gene regulation
AM Moreno, X Fu, J Zhu, D Katrekar, YRV Shih, J Marlett, J Cabotaje, ...
Molecular Therapy 26 (7), 1818-1827, 2018
1512018
Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs
D Katrekar, J Yen, Y Xiang, A Saha, D Meluzzi, Y Savva, P Mali
Nature biotechnology 40 (6), 938-945, 2022
762022
Oligonucleotide conjugated multi-functional adeno-associated viruses
D Katrekar, AM Moreno, G Chen, A Worlikar, P Mali
Scientific reports 8 (1), 3589, 2018
472018
RNA editing: Expanding the potential of RNA therapeutics
BJ Booth, S Nourreddine, D Katrekar, Y Savva, D Bose, TJ Long, DJ Huss, ...
Molecular Therapy 31 (6), 1533-1549, 2023
272023
RNA-guided adenosine deaminases: advances and challenges for therapeutic RNA editing
G Chen, D Katrekar, P Mali
Biochemistry 58 (15), 1947-1957, 2019
232019
Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificity
D Katrekar, Y Xiang, N Palmer, A Saha, D Meluzzi, P Mali
Elife 11, e75555, 2022
212022
Programmatic introduction of parenchymal cell types into blood vessel organoids
A Dailamy, U Parekh, D Katrekar, A Kumar, D McDonald, A Moreno, ...
Stem Cell Reports 16 (10), 2432-2441, 2021
122021
In vivo RNA targeting of point mutations via suppressor tRNAs and adenosine deaminases
D Katrekar, P Mali
bioRxiv, 210278, 2017
122017
Advances in CRISPR-Cas based genome engineering
D Katrekar, M Hu, P Mali
Current Opinion in Biomedical Engineering 1, 78-86, 2017
112017
Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editing
Y Xiang, D Katrekar, P Mali
Methods 205, 158-166, 2022
62022
Robust RNA editing via recruitment of endogenous ADARs using circular guide RNAs
D Katrekar, J Yen, Y Xiang, A Saha, D Meluzzi, Y Savva, P Mali
bioRxiv, 2021.01. 12.426286, 2021
62021
Rna and dna base editing via engineered adar recruitment
P Mali, D Katrekar, D Meluzzi, G Chen, KM Ford
US Patent App. 17/273,885, 2022
42022
RNA targeting of mutations via suppressor tRNAs and deaminases
P Mali, D Katrekar
US Patent 11,479,775, 2022
32022
Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA base-editing activity, functionality and specificity
D Katrekar, N Palmer, Y Xiang, A Saha, D Meluzzi, P Mali
Biorxiv, 2020.09. 08.288233, 2020
32020
RNA targeting of mutations via suppressor tRNAs and deaminases
P Mali, D Katrekar
US Patent 11,932,856, 2024
22024
RNA TARGETING OF MUTATIONS VIA SUPPESSOR tRNAs AND DEAMINASES
P Mali, D Katrekar
US Patent App. 17/170,693, 2021
12021
Crispr-cas genome engineering via a modular aav delivery system
P Mali, D Katrekar, AM Collado
US Patent App. 16/325,679, 2020
12020
Facile capsid pseudotyping via unnatural amino acid (UAA) based site-specific modification of AAV2 and AAV-DJ capsids and engineering of AAVs
D Katrekar, AM Moreno, P Mali
MOLECULAR THERAPY 25 (5), 336-337, 2017
12017
Rna and dna base editing via engineered adar recruitment
M Prashant, D Katrekar, D Meluzzi, C Genghao, MF Kyle
2024
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20